Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders

Details for Australian Patent Application No. 2006274733 (hide)

Owner AstraZeneca AB

Inventors Andrews, David; Finlay, Maurice Raymond; Green, Clive; Jones, Clifford

Agent Davies Collison Cave

Pub. Number AU-B-2006274733

PCT Pub. Number WO2007/015064

Priority 0520281.7 06.10.05 GB; 0526015.3 22.12.05 GB; 0608371.1 28.04.06 GB; 0515743.3 30.07.05 GB

Filing date 27 July 2006

Wipo publication date 8 February 2007

Acceptance publication date 16 September 2010

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/015064 Priority application(s): WO2007/015064

16 September 2010 Application Accepted

  Published as AU-B-2006274733

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006274748-Gangway apparatus

2006274729-Methods of forming packs in a plurality of perforations in a casing of a wellbore